PROFUND ADVISORS LLC

Position in KYMR — Kymera Therapeutics, Inc.

CIK 1129919 BETHESDA, MD

Position in KYMR

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,116,234

+$22,074 QoQ

Shares Held

18,455

-26.6% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#121

of 271 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. KYMR ranks #8 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc. This page	18,455	$2,116,234

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,116,234	18,455	-26.6%	Shares	Sole	2026-08-11
2026-03-31	$2,094,160	25,143	+13.1%	Shares	Sole	2026-04-27
2025-12-31	$1,730,494	22,240	+48.1%	Shares	Sole	2026-02-06
2025-09-30	$849,735	15,013	+70.0%	Shares	Sole	2025-11-06
2025-06-30	$385,384	8,831	-29.6%	Shares	Sole	2025-08-07
2025-03-31	$343,466	12,549	+9.2%	Shares	Sole	2025-05-08
2024-12-31	$462,524	11,497	-13.6%	Shares	Sole	2025-02-14
2024-09-30	$630,009	13,311	-21.8%	Shares	Sole	2024-11-14
2024-06-30	$507,778	17,011	-48.2%	Shares	Sole	2024-08-13
2024-03-31	$1,319,565	32,825	+65.1%	Shares	Sole	2024-05-08
2023-12-31	$506,323	19,887	-21.9%	Shares	Sole	2024-02-14
2023-09-30	$353,810	25,454	-34.4%	Shares	Sole	2023-11-13
2023-06-30	$892,678	38,829	+0.2%	Shares	Sole	2023-08-10
2023-03-31	$1,147,806	38,738	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.